Last 7 days
2.8%
Last 30 days
0.3%
Last 90 days
2.7%
Trailing 12 Months
79.0%
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 3.5% | 805,500,000 | 778,000,000 | 739,600,000 | 690,900,000 | 653,100,000 |
S&GA Expenses | 1.6% | 202,300,000 | 199,100,000 | 206,300,000 | 186,800,000 | 173,800,000 |
EBITDA | 90.4% | -62,200,000 | -646,000,000 | -339,300,000 | 144,300,000 | - |
EBITDA Margin | 90.7% | -0.08 | -0.83 | -0.40 | 0.18 | - |
Earnings Before Taxes | 80.7% | -136,600,000 | -707,800,000 | -398,600,000 | 85,900,000 | 46,600,000 |
EBT Margin | 81.4% | -0.17 | -0.91 | -0.51 | 0.07 | - |
Interest Expenses | 9.6% | 20,600,000 | 18,800,000 | 17,000,000 | 18,900,000 | 21,700,000 |
Net Income | -13.5% | -576,800,000 | -508,000,000 | -328,800,000 | 18,500,000 | 39,200,000 |
Net Income Margin | -9.7% | -0.72 | -0.65 | -0.39 | 0.05 | - |
Free Cahsflow | 383.0% | 90,000,000 | -31,800,000 | 19,800,000 | 3,200,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 1.3% | 1,744 | 1,722 | 1,768 | 2,271 | 2,127 |
Current Assets | 2.4% | 797 | 778 | 850 | 826 | 1,001 |
Cash Equivalents | 1.0% | 466 | 462 | 439 | 451 | 679 |
Net PPE | -6.0% | 22.00 | 23.00 | 23.00 | 23.00 | 22.00 |
Goodwill | -0.1% | 370 | 370 | 370 | 796 | 170 |
Liabilities | 7.1% | 924 | 862 | 697 | 726 | 634 |
Current Liabilities | 19.9% | 490 | 409 | 163 | 171 | 183 |
Long Term Debt | -0.1% | 337 | 338 | 338 | 338 | - |
LT Debt, Current | 0% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 |
LT Debt, Non Current | -0.1% | 333 | 334 | 334 | 335 | 335 |
Shareholder's Equity | -4.5% | 821 | 859 | 1,071 | 1,546 | 1,493 |
Retained Earnings | -7.0% | -557 | -521 | -362 | 8.00 | 20.00 |
Additional Paid-In Capital | 0.5% | 1,183 | 1,177 | 1,166 | 1,160 | 1,101 |
Accumulated Depreciation | 5.2% | 32.00 | 31.00 | 29.00 | 27.00 | - |
Shares Outstanding | 0.6% | 177 | 176 | 173 | - | - |
Minority Interest | -3.7% | 193 | 201 | 265 | 375 | 370 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 539.5% | 98.00 | -22.30 | -23.70 | -41.20 | 78.00 |
Share Based Compensation | 19.6% | 44.00 | 37.00 | 27.00 | 15.00 | 11.00 |
Cashflow From Investing | -1.1% | -219 | -216 | -220 | -218 | -26.70 |
Cashflow From Financing | -90.4% | 1.00 | 13.00 | 16.00 | -79.10 | 524 |
97.3%
95.5%
47.3%
Y-axis is the maximum loss one would have experienced if Signify Health was unfortunately bought at previous high price.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-13 | Crystalline Management Inc. | new | - | 1,315,150 | 1,315,150 | 0.66% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -0.05 | -3,946 | 230,054 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | unchanged | - | - | 14,000 | -% |
2023-02-28 | Voya Investment Management LLC | added | 14.39 | 37,268 | 336,268 | -% |
2023-02-27 | Parallax Volatility Advisers, L.P. | new | - | 530,984 | 530,984 | -% |
2023-02-24 | NATIXIS | added | 72.68 | 9,016,570 | 21,938,600 | 0.12% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | -100 | -219,000 | - | -% |
2023-02-17 | TRUIST FINANCIAL CORP | sold off | -100 | -330,000 | - | -% |
2023-02-16 | American Trust | new | - | 233,636 | 233,636 | 0.02% |
2023-02-15 | ALLIANCEBERNSTEIN L.P. | added | 2.78 | 348,033 | 33,469,000 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 01, 2023 | new mountain investments v, l.l.c. | 27.1% | 48,378,865 | SC 13G/A | |
Feb 11, 2022 | new mountain investments v, l.l.c. | 28.4% | 48,378,865 | SC 13G | |
Feb 09, 2022 | ark investment management llc | 11.74% | 20,010,328 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-07 | Builder Josh | sold (taxes) | -125,906 | 28.37 | -4,438 | chief technology officer |
2023-03-07 | Pierre David | sold (taxes) | -186,221 | 28.37 | -6,564 | chief operating officer |
2023-03-07 | Armbrester Bradford Kyle | sold (taxes) | -180,689 | 28.37 | -6,369 | chief executive officer |
2023-03-07 | Senneff Steve | sold (taxes) | -160,574 | 28.37 | -5,660 | pres. chief fin. & admin. off. |
2023-03-07 | ORTON LAURENCE MICHAEL | sold (taxes) | -32,909 | 28.37 | -1,160 | chief accounting officer |
2023-03-07 | Gronniger Tim | sold (taxes) | -108,402 | 28.37 | -3,821 | ch. value-based sols. off |
2023-03-07 | Rothman Marc D | sold (taxes) | -77,620 | 28.37 | -2,736 | chief medical officer |
2023-03-07 | McAnaney Adam | sold (taxes) | -106,388 | 28.37 | -3,750 | general counsel and secretary |
2023-02-27 | McAnaney Adam | acquired | - | - | 52,102 | general counsel and secretary |
2023-02-27 | Rothman Marc D | acquired | - | - | 34,735 | chief medical officer |
Consolidated Statements of Operations - USD ($) $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 805.5 | $ 653.1 | $ 450.6 |
Operating expenses | |||
Service expense (exclusive of depreciation and amortization shown below) | 440.4 | 351.5 | 265.0 |
Selling, general and administrative expense (exclusive of depreciation and amortization, shown below) | 202.3 | 173.8 | 145.1 |
Transaction-related expenses | 23.8 | 9.9 | 11.4 |
Restructuring expenses | 2.1 | 0.0 | |
Loss on impairment | 3.3 | 0.0 | 0.8 |
Depreciation and amortization | 53.8 | 41.8 | 35.8 |
Total operating expenses | 725.7 | 577.0 | 458.1 |
Income (loss) from continuing operations | 79.8 | 76.1 | (7.5) |
Interest expense | 20.6 | 21.7 | 22.2 |
Loss on extinguishment of debt | 0.0 | 5.0 | 0.0 |
Other (income) expense | 195.8 | 2.8 | 9.0 |
Other (income) expense, net | 216.4 | 29.5 | 31.2 |
(Loss) income from continuing operations before income taxes | (136.6) | 46.6 | (38.7) |
Income tax (benefit) expense | (6.2) | 13.7 | 0.9 |
Net (loss) income from continuing operations | (130.4) | 32.9 | (39.6) |
(Loss) income from discontinued operations, net of tax | (653.3) | (23.0) | 25.1 |
Net (loss) income | (783.7) | $ 9.9 | (14.5) |
Net (loss) income attributable to noncontrolling interest | (206.9) | ||
Net (loss) income attributable to Signify Health, Inc. | $ (576.8) | $ (14.5) | |
(Loss) earnings per share of Class A common stock - continuing operations | |||
Basic (in dollars per share) | $ (0.55) | $ 0.20 | |
Diluted (in dollars per share) | $ (0.55) | $ 0.19 | |
Weighted average shares of Class A common stock outstanding | |||
Basic (in shares) | 176,293,666 | 168,662,126 | |
Diluted (in shares) | 176,293,666 | 172,064,800 |
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 466.1 | $ 678.5 |
Accounts receivable, net | 156.4 | 117.1 |
Contract assets | 26.6 | 1.5 |
Restricted cash | 27.3 | 0.0 |
Prepaid expenses and other current assets | 27.3 | 13.8 |
Current assets of discontinued operations | 92.8 | 189.7 |
Total current assets | 796.5 | 1,000.6 |
Property and equipment, net | 21.9 | 21.5 |
Goodwill | 369.9 | 170.4 |
Intangible assets, net | 418.3 | 352.6 |
Operating lease right-of-use assets | 22.3 | 0.0 |
Deferred tax assets | 106.0 | 38.8 |
Other assets | 9.2 | 11.0 |
Noncurrent assets of discontinued operations | 0.0 | 532.3 |
Total assets | 1,744.1 | 2,127.2 |
Current liabilities | ||
Accounts payable and accrued expenses | 84.1 | 54.7 |
Contract liabilities | 4.4 | 5.1 |
Current maturities of long-term debt | 3.5 | 3.5 |
Current Customer EAR liability | 276.7 | 0.0 |
Current tax receivable agreement liability | 5.1 | 0.0 |
Other current liabilities | 10.3 | 7.7 |
Current liabilities of discontinued operations | 106.3 | 112.1 |
Total current liabilities | 490.4 | 183.1 |
Long-term debt | 333.1 | 334.9 |
Customer EAR liability | 0.0 | 48.6 |
Tax receivable agreement liability | 54.0 | 56.3 |
Deferred tax liabilities | 19.6 | 0.0 |
Noncurrent operating lease liabilities | 25.5 | 0.0 |
Other noncurrent liabilities | 0.9 | 10.0 |
Noncurrent liabilities of discontinued operations | 0.0 | 1.4 |
Total liabilities | 923.5 | 634.3 |
Commitments and Contingencies (Note 21) | ||
Additional paid-in capital | 1,182.5 | 1,101.3 |
(Accumulated deficit) Retained earnings | (557.5) | 19.7 |
Contingently redeemable noncontrolling interest | 193.2 | 369.6 |
Total stockholders' equity | 820.6 | 1,492.9 |
Total liabilities and stockholders' equity | 1,744.1 | 2,127.2 |
Class A Common Stock | ||
Current liabilities | ||
Common stock | 1.8 | 1.7 |
Class B Common Stock | ||
Current liabilities | ||
Common stock | $ 0.6 | $ 0.6 |